Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PharmEasy

Explore full profile

Online pharmacy, diagnostics, and teleconsultation healthcare platform.

Mumbai, IndiaFounded 2015Health Tech & Medtech
Valuation $500M–1B Last recorded · 2026
Revenue $50–100M Latest reported FY
Headcount 2–5k Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PharmEasy and the history behind them.

At a glance

Founded
2015
Headquarters
Mumbai, India
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning PharmEasy.

See all news

Investors

31 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later30 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 9 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
20 countries with
team presence
🇮🇳 India96.9%
🇦🇪 United Arab Emirates0.4%
🇺🇸 United States0.4%
🇪🇬 Egypt0.3%
🇨🇦 Canada0.2%
Top 5 of 20 shown
Web traffic by country
9.1M monthly visits
across markets
🇮🇳 India92.5%
🇺🇸 United States1.7%
🇬🇧 United Kingdom0.5%
🇦🇪 United Arab Emirates0.4%
🇸🇬 Singapore0.3%
Top 5 markets shown

Investments and acquisitions

Disclosed deals where PharmEasy was the backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across PharmEasy's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        PharmEasy's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about PharmEasy on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See PharmEasy on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.